e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis, non-specific interstitial pneumonia and human donor lungs
M. Korfei, C. Ruppert, P. Markart, S. Schmitt, G. Lang, K. Preissner, W. Seeger, A. Guenther (Giessen, Germany; Vienna, Austria)
Source:
Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Session:
Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Session type:
Thematic Poster Session
Number:
3483
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Korfei, C. Ruppert, P. Markart, S. Schmitt, G. Lang, K. Preissner, W. Seeger, A. Guenther (Giessen, Germany; Vienna, Austria). Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis, non-specific interstitial pneumonia and human donor lungs. Eur Respir J 2008; 32: Suppl. 52, 3483
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
From pulmonary gas exchange to the interpretation of arterial blood gases
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and non-specific interstitial pneumonia (NSIP)
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Analysis of the lung microbiota in healthy dogs and in canine idiopathic pulmonary fibrosis, a possible spontaneous model for human IPF.
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018
Comparison of clinical features between patients of lung cancer with combined pulmonary fibrosis and emphysema syndrome and those with interstitial pneumonia
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012
Expression of TGF-β1 and TGFβ receptors in lung tissue of patients with idiopathic interstitial pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 312s
Year: 2002
Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2008; 32: 170-174
Year: 2008
Lysozyme level and activity are decreased in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and potentially contribute to increased susceptibility to pulmonary infection
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006
Pertechnegas lung clearance in different forms of interstitial lung disease
Source: Eur Respir J 2002; 19: 31-36
Year: 2002
The clinical value of surgical lung biopsy in 166 patients with suspected interstitial lung disease
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Proteomic investigation in blood of patients with idiopathic interstitial pneumonia
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease
Source: Eur Respir Rev 2009; 18: 129-132
Year: 2009
Markers of fibrosis and tissue destruction in usual interstitial pneumonia associated with pulmonary emphysema
Source: Eur Respir J 2007; 30: Suppl. 51, 489s
Year: 2007
Cytokine profiles in the lungs of patients with interstitial and obstructive lung diseases
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018
Clinical features of usual interstitial pneumonia-correlation between idiopathic pulmonary fibrosis and connective tissue disease associated with usual interstitial pneumonia
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Morphologic evaluation of lung in a scleroderma-like rabbit model
Source: Annual Congress 2006 - Systemic diseases, environmental and genetic factors in interstitial lung disease
Year: 2006
Overall survival is significantly higher in sarcoidosis than in IPF patients after lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Increased polysialylation in lung tissue of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - Cell biology of lung disease
Year: 2011
Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia
Source: Eur Respir J 2009; 33: 68-76
Year: 2009
Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias
Source: Eur Respir J 2011; 37: 1119-1127
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept